A Presentation by Samir Mitragotri
Effective delivery of therapeutics is a major problem in today’s healthcare. At a fundamental level, the challenge of therapeutic delivery reflects the fact that the drug distribution in the body is limited by body’s natural metabolic processes and transport barriers. These biological barriers, while serving an important purpose of regulating body’s metabolic functions, limit the drug dose that ultimately reaches the target site. Accordingly, many drugs fail to reach their full therapeutic potential. We are developing a fundamental understanding of body’s key biological barriers and using this understanding to develop novel means to negotiate these barriers to deliver drugs. Samir Mitragotri will present an overview of the lessons learned from his exploration of these biological barriers.
________________________________________________________________________________________________________________
Samir Mitragotri is the Hiller Professor of Bioengineering and Wyss Professor of Biologically Inspired Engineering at Harvard University. Prior to this, he was the Mellichamp Chair Professor in the Department of Chemical Engineering at the University of California, Santa Barbara. His research is focused on novel strategies for drug delivery. He is an elected member of the National Academy of Engineering, National Academy of Medicine and National Academy of Inventors. He is also an elected fellow of AAAS, CRS, BMES, AIMBE, and AAPS. He is an author of over 250 publications, an inventor on over 170 patent/patent applications, and a Thomson Reuters Highly Cited Researcher. He received his BS in Chemical Engineering from the Institute of Chemical Technology, India and a PhD in Chemical Engineering from the Massachusetts Institute of Technology. He is the Editor-in-Chief of AIChE’s and SBE’s new journal Bioengineering and Translational Medicine.
As usual, the talk is free.
Door: 6:00pm / Talk: 6:30pm
February 13, 2019